1. Poon, MTC, Fonville, AF, Al-Shahi Salman, R. Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2014; 85: 660–667.
Google Scholar | Crossref | Medline | ISI2. Meretoja, A, Strbian, D, Putaala, J, et al. SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke 2012; 43: 2592–2597.
Google Scholar | Crossref | Medline | ISI3. Al-Shahi Salman, R, Frantzias, J, Lee, RJ, et al. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data. Lancet Neurol 2018; 17: 885–894.
Google Scholar | Crossref | Medline4. Camps-Renom, P, Alejaldre-Monforte, A, Delgado-Mederos, R, et al. Does prior antiplatelet therapy influence hematoma volume and hematoma growth following intracerebral hemorrhage? Results from a prospective study and a meta-analysis. Eur J Neurol 2017; 24: 302–308.
Google Scholar | Crossref | Medline5. Toyoda, K, Okada, Y, Minematsu, K, et al. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology 2005; 65: 1000–1004.
Google Scholar | Crossref | Medline | ISI6. Kuramatsu, JB, Mauer, C, Kiphuth, IC, et al. Reported antiplatelet use influences long-term outcome independently in deep intracerebral hemorrhage. Neurosurgery 2012; 70: 342–350; discussion 50.
Google Scholar | Crossref | Medline7. Lacut, K, Le Gal, G, Seizeur, R, et al. Antiplatelet drug use preceding the onset of intracerebral hemorrhage is associated with increased mortality. Fundam Clin Pharmacol 2007; 21: 327–333.
Google Scholar | Crossref | Medline | ISI8. Roquer, J, Vivanco Hidalgo, RM, Ois, A, et al. Antithrombotic pretreatment increases very-early mortality in primary intracerebral hemorrhage. Neurology 2017; 88: 885–891.
Google Scholar | Crossref | Medline9. Saloheimo, P, Ahonen, M, Juvela, S, et al. Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke 2006; 37: 129–133.
Google Scholar | Crossref | Medline | ISI10. van Ginneken, V, Engel, P, Fiebach, JB, et al. Prior antiplatelet therapy is not associated with larger hematoma volume or hematoma growth in intracerebral hemorrhage. Neurol Sci 2018; 39: 745–748.
Google Scholar | Crossref | Medline11. Yang, NR, Kim, SJ, Seo, EK. Spontaneous intracerebral hemorrhage with antiplatelets/anticoagulants/none: a comparison analysis. Acta Neurochirurgica 2014; 156: 1319–1325.
Google Scholar | Crossref | Medline12. Liberati, A, Altman, DG, Tetzlaff, J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700.
Google Scholar | Crossref | Medline13. Seiffge, DJ, Goeldlin, MB, Tatlisumak, T, et al. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use. J Neurol 2019; 266: 3126–3135.
Google Scholar | Crossref | Medline14. Cochrane Bias Methods Group. Tool to Assess Risk of Bias in Cohort Studies.
Google Scholar15. Creutzfeldt, CJ, Weinstein, JR, Longstreth, WT, et al. Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage. J Stroke Cerebrovasc Dis 2009; 18: 221–228.
Google Scholar | Crossref | Medline | ISI16. Baharoglu, MI, Cordonnier, C, Salman, RAS, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet 2016; 387: 2605–2613.
Google Scholar | Crossref | Medline17. Roquer, J, Vivanco-Hidalgo, RM, Prats-Sánchez, LL, et al. Interaction of atrial fibrillation and antithrombotics on outcome in intracerebral hemorrhage. Neurology 2019; 93: e1820–e1829.
Google Scholar | Crossref | Medline18. Hanger, HC, Fletcher, VJ, Wilkinson, TJ, et al. Effect of aspirin and warfarin on early survival after intracerebral haemorrhage. J Neurol 2008; 255: 347–352.
Google Scholar | Crossref | Medline19. Ishibashi, A, Yokokura, Y, Adachi, H. Is antiplatelet therapy for the prevention of ischemic stroke associated with the prognosis of intracerebral hemorrhage? Kurume Med J 2008; 55: 71–75.
Google Scholar | Crossref | Medline20. Moussouttas, M, Malhotra, R, Fernandez, L, et al. Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage. Neurocrit Care 2010; 12: 24–29.
Google Scholar | Crossref | Medline | ISI21. Stead, LG, Jain, A, Bellolio, MF, et al. Effect of anticoagulant and antiplatelet therapy in patients with spontaneous intra-cerebral hemorrhage: does medication use predict worse outcome? Clin Neurol Neurosurg 2010; 112: 275–281.
Google Scholar | Crossref | Medline | ISI22. Yildiz, OK, Arsava, EM, Akpinar, E, et al. Previous antiplatelet use is associated with hematoma expansion in patients with spontaneous intracerebral hemorrhage. J Stroke Cerebrovasc Dis 2012; 21: 760–766.
Google Scholar | Crossref | Medline23. Okada, T, Nakase, T, Sasaki, M, et al. Do the antithrombotic therapy at the time of intracerebral hemorrhage influence clinical outcome? analysis between the difference of antiplatelet and anticoagulant agents and clinical course. J Stroke Cerebrovasc Dis 2014; 23: 1781–1788.
Google Scholar | Crossref | Medline24. Hokari, M, Shimbo, D, Asaoka, K, et al. Impact of antiplatelets and anticoagulants on the prognosis of intracerebral hemorrhage. J Stroke Cerebrovasc Dis 2018; 27: 53–60.
Google Scholar | Crossref | Medline25. Caso, V, Paciaroni, M, Venti, M, et al. Effect of on-admission antiplatelet treatment on patients with cerebral hemorrhage. Cerebrovasc Dis 2007; 24: 215–218.
Google Scholar | Crossref | Medline26. Sansing, LH, Messe, SR, Cucchiara, BL, et al. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology 2009; 72: 1397–1402.
Google Scholar | Crossref | Medline | ISI27. Chen, YW, Tang, SC, Tsai, LK, et al. Pre-ICH warfarin use, not antiplatelets, increased case fatality in spontaneous ICH patients. Eur J Neurol 2013; 20: 1128–1134.
Google Scholar | Crossref | Medline28. Foerch, C, Sitzer, M, Steinmetz, H, et al. Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage. Stroke 2006; 37: 2165–2167.
Google Scholar | Crossref | Medline | ISI29. Sprügel, MI, Kuramatsu, JB, Gerner, ST, et al. Antiplatelet therapy in primary spontaneous and oral anticoagulation-associated intracerebral hemorrhage. Stroke 2018; 49: 2621–2629.
Google Scholar | Crossref | Medline30. Khan, NI, Siddiqui, FM, Goldstein, JN, et al. Association between previous use of antiplatelet therapy and intracerebral hemorrhage outcomes. Stroke 2017; 48: 1810–1817.
Google Scholar | Crossref | Medline31. Romem, R, Tanne, D, Geva, D, et al. Antithrombotic treatment prior to intracerebral hemorrhage: analysis in the National acute stroke Israeli registry. J Stroke Cerebrovasc Dis 2018; 27: 3380–3386.
Google Scholar | Crossref | Medline32. Béjot, Y, Cordonnier, C, Durier, J, et al. Intracerebral haemorrhage profiles are changing: results from the Dijon population-based study. Brain 2013; 136: 658–664.
Google Scholar | Crossref | Medline | ISI33. Qureshi, AI, Palesch, YY, Barsan, WG, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. New Engl J Med 2016; 375: 1033–1043.
Google Scholar | Crossref | Medline | ISI34. Anderson, CS, Heeley, E, Huang, Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. New Engl J Med 2013; 368: 2355–2365.
Google Scholar | Crossref | Medline | ISI35. DiNicolantonio, JJ, D’Ascenzo, F, Tomek, A, et al. Clopidogrel is safer than ticagrelor in regard to bleeds: a closer look at the PLATO trial. Int J Cardiol 2013; 168: 1739–1744.
Google Scholar | Crossref | Medline36. Cuisset, T, Deharo, P, Quilici, J, et al. Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study. Eur Heart J 2017; 38: 3070–3078.
Google Scholar | Crossref | Medline37. Rodriguez-Luna, D, Boyko, M, Subramaniam, S, et al. Magnitude of hematoma volume measurement error in intracerebral hemorrhage. Stroke 2016; 47: 1124–1126.
Google Scholar | Crossref | Medline | ISI38. Hemphill, JC, Bonovich, DC, Besmertis, L, et al. The ICH Score. Stroke 2001; 32: 891–897.
Google Scholar | Crossref | Medline | ISI39. Murthy, S, Roh, DJ, Chatterjee, A, et al. Prior antiplatelet therapy and haematoma expansion after primary intracerebral haemorrhage: an individual patient-level analysis of CLEAR III, MISTIE III and VISTA-ICH. J Neurol Neurosurg Psychiatry. 2020. DOI: 10.1136/jnnp-2020-323458.
Google Scholar | Crossref | Medline40. Thompson, BB, Bejot, Y, Caso, V, et al. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology 2010; 75: 1333–1342.
Google Scholar | Crossref | Medline | ISI41. Lees, KR, Bath, PMW, Schellinger, PD, et al. Contemporary outcome measures in acute stroke research. Stroke 2012; 43: 1163–1170.
Google Scholar | Crossref | Medline | ISI42. Salinas, J, Sprinkhuizen, SM, Ackerson, T, et al. An International standard set of patient-centered outcome measures after stroke. Stroke 2016; 47: 180–186.
Google Scholar | Crossref | Medline43. Al-Shahi Salman, R, Dennis, MS, Sandercock, PAG, et al. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial. Lancet 2019; 393: 2613–2623.
Google Scholar | Crossref | Medline